Leadership & Pay ·
Alethia Young resigns from the Board of Directors of PTC Therapeutics to become an advisor through June 2027
PTCTPtc Therapeutics, Inc.
Alethia Young resigned from the Board of Directors of PTC Therapeutics, Inc. effective June 8, 2026. She will transition to a consulting role as an advisor to the company through June 8, 2027, receiving a monthly consulting fee of $4,166.67. PTC Therapeutics, Inc. is a biotechnology company focused on developing and commercializing therapeutic solutions.